Skip to main content

CME

Stock
Financials
Financial Data & Stock Exchanges

Performance overview

CME Price
Price Chart

Forward-looking statistics

Beta
0.40
Risk
17.16%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The CME was founded in 1898 and in 2002 completed its initial public offering. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival, CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX in 2018, it has also expanded into cash foreign exchange, fixed income trading, and collateral optimization.

Company info

SectorFinancials
IndustryFinancial Data & Stock Exchanges
Employees5K
Market cap$71.8B

Fundamentals

Enterprise value$101.6B
Revenue$6.3B
Revenue per employee
Profit margin57.81%
Debt to equity14.04

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)$9.93
Dividend per share$5.00
Revenue per share$17.45
Avg trading volume (30 day)$702M
Avg trading volume (10 day)$821M
Put-call ratio

Macro factor sensitivity

Growth+2.5
Credit+0.8
Liquidity-0.2
Inflation+0.5
Commodities+0.1
Interest Rates-1.1

Valuation

Dividend yield1.81%
PEG Ratio26.68
Price to sales15.89
P/E Ratio26.68
Enterprise Value to Revenue16.19
Price to book3.68

Upcoming events

Next earnings dayApril 23, 2025
Next dividend day
Ex. dividend dayJune 9, 2025

News

Will CME (CME) Beat Estimates Again in Its Next Earnings Report?

CME (CME) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Investment Research (July 10, 2025)
Final Trades: Berkshire Hathaway, Vertex Pharma, S&P Global and CME Group

Final Trades are in! The Investment Committee reveals their top picks to close out the day—don't miss it!

CNBC Television (April 30, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free